NASDAQ
03.06.24
21:59 Uhr
0,149 US-Dollar
+0,004
+2,76 %
+2,76 %
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02.04. | Galera Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 25.02. | Galera Therapeutics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 31.12.24 | Galera Therapeutics completes acquisition of Nova Pharmaceuticals | 406 | GlobeNewswire (Europe) | Galera's development strategy shifts from toxicity reduction to anti-cancer therapeutics, with three trials in patients with highly resistant subsets of advanced breast cancer. Lead program is Phase... ► Artikel lesen | |
| 31.12.24 | Galera Therapeutics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 20.12.24 | Galera Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 13.12.24 | Galera Therapeutics, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 15.11.24 | Galera Therapeutics, Inc. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB | 1 | SEC Filings | ||
| 04.09.24 | Delisting of Securities of Liberty Resources Acquisition Corp.; Achari Ventures Holdings Corp. I; PetVivo Holdings, Inc.; Galera Therapeutics, Inc.; Clean Energy Special Situations Corp.; Capitalworks Emerging Markets Acquisition ... | 149 | GlobeNewswire (Europe) | NEW YORK, Sept. 04, 2024 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock, units, and warrants of Liberty Resources Acquisition Corp. Liberty Resources... ► Artikel lesen | |
| GALERA THERAPEUTICS Aktie jetzt für 0€ handeln | |||||
| 14.08.24 | Galera Therapeutics: Galera Announces Board Approval of Complete Liquidation and Dissolution | 203 | GlobeNewswire (Europe) | MALVERN, Pa., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company historically focused on developing a pipeline of novel, proprietary... ► Artikel lesen | |
| 13.05.24 | Galera Therapeutics: Galera Reports First Quarter 2024 Financial Results and Recent Corporate Updates | 264 | GlobeNewswire (Europe) | MALVERN, Pa., May 13, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel, proprietary therapeutics... ► Artikel lesen | |
| 03.05.24 | Galera Therapeutics: Galera Adopts Limited Duration Stockholder Rights Agreement | 331 | GlobeNewswire (Europe) | MALVERN, Pa., May 03, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a biopharmaceutical company focused on developing a pipeline of novel, proprietary therapeutics that have the... ► Artikel lesen |
11 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EVOTEC | 7,382 | +0,52 % | Aktien KW 16 Erholung. Aber: Death Cross als Crash-Menetekel? Oder gibt's Hoffnung? News. Rheinmetall. Kontron. Evotec. Nvidia. Hamborner REIT. MHP Hotels. Forvia Hella. Hensoldt. Circus. Berentzen. Fortec. Carl Zeiss MediTec. Drägerwerk. Agnicio Mining | Aktien Wochenrückblick - die Märkte scheinen sich langsam an die Zitterphase zu gewöhnen. Aktuelle Kurserholung dauerhaft? Oder was kommt noch: Zollankündigung, Handelskrieg mit China, 90 Tage Moratorium... ► Artikel lesen | |
| CRISPR THERAPEUTICS | 33,800 | -1,74 % | CRISPR Therapeutics to Report Q1 Earnings: What's in the Cards? | ||
| MAINZ BIOMED | 2,775 | -100,00 % | Mainz Biomed Aktie: Platzt am Montag die Bombe? Diese Neuigkeiten müssen Anleger dringend beachten! | ||
| TREVENA | 0,153 | 0,00 % | Delisting of Securities of Patria Latin American Opportunity Acquisition Corp.; Trevena, Inc.; Seelos Therapeutics, Inc.; DP Cap Acquisition Corp I; Chain Bridge I; Qomolangma Acquisition Corp.; Gaucho Group Holdings, Inc. ... | NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the Class A Ordinary Shares, unit, and warrant of Patria Latin American Opportunity Acquisition... ► Artikel lesen | |
| CELLECTAR BIOSCIENCES | 0,276 | +0,73 % | Cellectar Biosciences: Zwischen Hoffnung und harten Realitäten | Biotech-Firma Cellectar meldet Erfolge in der Krebstherapie, kämpft jedoch mit NASDAQ-Delisting und drastischen Kostensenkungen. Wie geht es weiter? NASDAQ-Listing in Gefahr - Was steckt dahinter?AnzeigeSollten... ► Artikel lesen | |
| GALAPAGOS NV | 23,420 | +1,30 % | Galapagos NV: Galapagos Reports First Quarter 2025 Financial Results, Recent Business Highlights and Near-Term Catalysts | First U.S. patient dosed in ATALANTA-1 study of GLPG5101
Mantle cell lymphoma (MCL), a high-unmet-need hematological malignancy, selected as lead indication for the GLPG5101 program; Pivotal development... ► Artikel lesen | |
| CENTOGENE | 0,102 | 0,00 % | Research and Markets: Europe Hereditary Genetic Testing Market Research 2024-2033, Competitive Analysis of Centogene, Eurofins Scientific, and F. Hoffmann-La Roche - ResearchAndMarkets.com | The "Europe Hereditary Genetic Testing Market: Focus on Genetic Testing Type and Country Analysis and Forecast, 2024-2033" report has been added to ResearchAndMarkets.com's offering.
The Europe... ► Artikel lesen | |
| NOVOCURE | 15,755 | -3,20 % | Novocure Reports First Quarter 2025 Financial Results | Quarterly net revenues of $155 million, up 12% year-over-year, with 4,268 active patients on therapy as of March 31, 2025 Results from Phase 3 PANOVA-3 trial in pancreatic cancer accepted as... ► Artikel lesen | |
| SENSEI BIOTHERAPEUTICS | 0,361 | +9,39 % | Sensei Biotherapeutics Reports Full Year 2024 Financial Results and Update on Clinical Progress | - Preliminary efficacy data from Phase 1/2 dose expansion cohort show durable responses and tumor shrinkage in a PD-(L)1 resistant "hot" tumor patient population - - Solnerstotug continues to demonstrate... ► Artikel lesen | |
| CHIMERIX | 7,510 | 0,00 % | XFRA CXF: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILCHIMERIX INC. DL... ► Artikel lesen | |
| AC IMMUNE | 1,466 | +1,38 % | AC Immune SA: AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate Update | AC Immune Reports Full Year 2024 Financial Results and Provides a Corporate Update Landmark exclusive option and license deal with Takeda for ACI-24.060 with $100 million upfront and additional potential... ► Artikel lesen | |
| CYTOMX THERAPEUTICS | 0,644 | -4,31 % | CytomX Therapeutics Aktie: Schwieriger als gedacht! | Biotechnologieunternehmen strafft Organisation um 40 Prozent, priorisiert Krebswirkstoff-Konjugat und verlängert Finanzierungshorizont bis ins zweite Quartal 2026 CytomX Therapeutics befindet sich in... ► Artikel lesen | |
| CYTOKINETICS | 35,000 | -1,69 % | Cytokinetics gains as Barclays initiates bullish view on lead drug's approval | ||
| SPERO THERAPEUTICS | 0,665 | +3,42 % | The Spero Clinic: When a Simple Ankle Injury Turns Into CRPS: Moana Ruhfass's Journey | FAYETTEVILLE, ARKANSAS / ACCESS Newswire / April 8, 2025 / While, for most children, life is an adventure and a never-ending road of discovery, many others are not that lucky, facing a journey of pain... ► Artikel lesen | |
| VANDA PHARMACEUTICALS | 3,680 | -2,65 % | Vanda Pharmaceuticals Inc.: FDA Bureaucrats Unlawfully Delay Hearing on Vanda Drug and Falsely Blame Commissioner Makary and the reductions in force at FDA | WASHINGTON, April 23, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. ("Vanda") (Nasdaq: VNDA) today announced that FDA bureaucrats have committed to delay Vanda's... ► Artikel lesen |
Das Unternehmen GALERA THERAPEUTICS INC kann der Branche Biotechnologie zugeordnet werden. Die relative Kursveränderung beträgt aktuell +2,76 % bei einem Aktienkurs von 0,149 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GALERA THERAPEUTICS INC finden Sie auf Wallstreet Online.
